141 related articles for article (PubMed ID: 581766)
1. Thyroid suppression test and outcome of hyperthyroidism treated with antithyroid drugs and triiodothyronine.
Yamamoto M; Igarashi T; Kimura S; Tsukamoto S; Togawa K; Ogata E
J Clin Endocrinol Metab; 1979 Jan; 48(1):72-7. PubMed ID: 581766
[No Abstract] [Full Text] [Related]
2. Low remission after therapy for Graves disease. Possible relation of dietary iodine with antithyroid therapy results.
Wartofsky L
JAMA; 1973 Nov; 226(9):1083-8. PubMed ID: 4800469
[No Abstract] [Full Text] [Related]
3. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
[TBL] [Abstract][Full Text] [Related]
4. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Buerklin EM; Schimmel M; Utiger RD
J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
[TBL] [Abstract][Full Text] [Related]
5. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
Izumi M; Larsen PR
J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
[TBL] [Abstract][Full Text] [Related]
6. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
8. The use of the E-rosette as a test for remission in Graves' disease treated with antithyroid drugs.
Farid NR; Munro R; Row VV; Volpé R
Clin Endocrinol (Oxf); 1974 Jan; 3(1):55-61. PubMed ID: 4407296
[No Abstract] [Full Text] [Related]
9. Antithyroid drugs.
Cooper DS
N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
[No Abstract] [Full Text] [Related]
10. Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
Wils JA; Kloppenborg PW
J Clin Endocrinol Metab; 1970 Mar; 30(3):406-7. PubMed ID: 4189571
[No Abstract] [Full Text] [Related]
11. Evaluation of the triiodothyronine suppression test in the treatment of Graves' disease.
Wils JA; Kloppenborg PW
Eur J Clin Invest; 1970 Aug; 1(2):90-3. PubMed ID: 4194884
[No Abstract] [Full Text] [Related]
12. Thyroid gland in Graves' disease: victim or culprit?
Chopra IJ; Solomon DH; Johnson DE; Chopra U
Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
[No Abstract] [Full Text] [Related]
13. Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves' disease.
Shi GM; Xu Q; Zhu CY; Yang YL
J Int Med Res; 2009; 37(2):576-82. PubMed ID: 19383254
[TBL] [Abstract][Full Text] [Related]
14. Thyroid suppression test as index of outcome of hyperthyroidism treated with antithyroid drugs.
Cassidy CE
Metabolism; 1970 Oct; 19(10):745-50. PubMed ID: 4096944
[No Abstract] [Full Text] [Related]
15. Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood.
Sills IN; Horlick MN; Rapaport R
J Pediatr; 1992 Aug; 121(2):206-9. PubMed ID: 1640284
[TBL] [Abstract][Full Text] [Related]
16. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
17. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
18. Human thyroid stimulating activity and clinical state in antithyroid treatment of juvenile Graves' disease.
Takata I; Suzuki Y; Saida K; Sato T
Acta Endocrinol (Copenh); 1980 May; 94(1):46-52. PubMed ID: 6247873
[No Abstract] [Full Text] [Related]
19. Remission rates of children and adolescents with thyrotoxicosis treated with antithyroid drugs.
Collen RJ; Landaw EM; Kaplan SA; Lippe BM
Pediatrics; 1980 Mar; 65(3):550-6. PubMed ID: 7360544
[No Abstract] [Full Text] [Related]
20. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies.
Cooper DS
J Clin Endocrinol Metab; 2003 Aug; 88(8):3474-81. PubMed ID: 12915620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
